Thyrogen Kit Shortage Update: What Patients Need to Know in 2026

If you rely on Thyrogen Kit (thyrotropin alfa) for your thyroid cancer follow-up care, you may have heard stories about previous shortages — or you may be encountering access difficulties right now. Either way, you need clear, accurate information about what is happening with Thyrogen availability in 2026. This update covers the current supply status, the history of past shortages, why access challenges still occur, and what you should do to protect your care.

Is Thyrogen Kit in Shortage Right Now?

As of 2026, Thyrogen Kit (thyrotropin alfa) is not listed on the FDA's official drug shortage database, nor on the ASHP (American Society of Health-System Pharmacists) shortage list. This is good news: there is no nationwide shortage of Thyrogen at this time.

However — and this is important — "not in shortage" does not mean "easy to get." Thyrogen Kit is a specialty biologic administered only in clinical settings. It is not stocked at retail pharmacies. Access challenges can still occur due to insurance authorization delays, specialty pharmacy logistics, facility scheduling, and regional distribution gaps. Many patients experience what could be called a practical access barrier even when supply is technically adequate.

The Thyrogen Shortage That Changed Everything: 2009–2012

The most significant Thyrogen shortage in history lasted approximately three years, beginning around 2009. The root cause: a viral contamination discovered at Genzyme's manufacturing facility in Allston, Massachusetts — the same plant used to produce Thyrogen and several other specialty biologics. Genzyme was forced to shut down or severely limit production while it worked to eliminate the contamination and restore safe manufacturing conditions.

The shortage was devastating for the thyroid cancer community. Thousands of patients who had been scheduled for Thyrogen-stimulated scans or radioiodine ablation were forced into the older, far more physically demanding thyroid hormone withdrawal (THW) protocol. Others had their surveillance delayed entirely. The shortage also came at a time when Thyrogen was gaining widespread clinical acceptance as the preferred preparation method, making its sudden unavailability all the more disruptive.

Genzyme ultimately resolved the manufacturing issues and restored supply. The company was later acquired by Sanofi, which has maintained production. That experience, however, highlighted a critical vulnerability: a complex biologic produced at a single manufacturing site, with no competitor or generic, creates enormous systemic risk for patients if anything goes wrong.

Why Thyrogen Kit Remains Vulnerable to Access Disruptions

Even without an active shortage, structural factors make Thyrogen prone to localized access disruptions:

No generic or biosimilar: Thyrotropin alfa has only one manufacturer worldwide for the U.S. market (Sanofi Genzyme). Any supply chain disruption at that single source affects every U.S. patient.

Specialty distribution: The drug moves through restricted specialty pharmacy and hospital supply chains, not broad retail networks.

Temperature-sensitive storage: Thyrogen must be stored at 2–8°C (refrigerated). Shipping and handling failures can render batches unusable.

Insurance bottlenecks: Prior authorization requirements frequently delay access even when supply is physically available.

What Should Patients Do Right Now?

Even in the absence of an active shortage, proactive steps help ensure your Thyrogen-based follow-up proceeds without disruption:

Schedule far in advance: Contact your endocrinologist or nuclear medicine team at least 6–8 weeks before your planned scan or ablation.

Start insurance auth early: Prior authorization can take 2–4 weeks. Your provider's office should initiate this the moment a Thyrogen procedure is planned.

Call ThyrogenONE: 1-888-497-6436. Sanofi Genzyme's support team can verify current availability and help connect you with facilities that stock the drug.

Use medfinder: medfinder contacts pharmacies on your behalf to locate Thyrogen Kit in your area.

Have a backup conversation with your doctor: Know in advance whether thyroid hormone withdrawal (THW) is an option for you if Thyrogen becomes unavailable.

The Bottom Line

There is no active nationwide Thyrogen Kit shortage in 2026. But the drug's specialty nature, single-manufacturer supply chain, and complex distribution system mean access challenges can and do occur. Learn more about why Thyrogen Kit is hard to find and take steps now to protect your follow-up care schedule.

Visit medfinder.com to find Thyrogen Kit at specialty pharmacies and facilities near you.